Mylan and Biocon file Herceptin biosimilar in Europe
First Herceptin biosimilar filed in EU, companies say.
X
Mylan and Biocon file Herceptin biosimilar in Europe
https://pharmaphorum.com/news/mylan-biocon-file-herceptin-biosimilar-europe/
biosimilar
No US Remicade biosimilar until at least October
Pfizer must wait until 180 day period ends, court fight ongoing.
Novartis’ Enbrel biosimilar closer to market
FDA committee recommends near-copy.
FDA advisers back Amgen’s Humira biosimilar
ABP 501 gets backing from FDA panel.
Sandoz biosimilar trial hailed as ‘landmark’
Patients switched between the originator and the near-copy.
Biosimilars don’t need big market share to bring savings – IMS
Competition can also drive down price of entire drug class.
US regulatory advisers to review Amgen’s Humira biosimilar
World’s biggest selling drug could face competition.
Janssen’s RA candidate among hot topics at EULAR
But attendees warned to expect “oceanic” weather.
